Product Information
PHENOBARBITAL 30 MG TABLET is a generic product labeled by Winder Laboratories LLC, priced at $0.1284 per EA under NDC 75826013810. Its NADAC has been published 394 times since Dec 12, 2018.
Strength
30 mg/1
Manufacturer
Winder Laboratories LLCNDC
75826013810
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
10/1/2018
Price Statistics
The NADAC for PHENOBARBITAL 30 MG TABLET has been published 394 times since Dec 12, 2018, and over the history we have for it it has declined 41.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1284 per EA |
|---|---|
| All-time high | $0.2865 (Jun 10, 2020) |
| All-time low | $0.0913 (Nov 20, 2024) |
| 52-week high | $0.1735 |
| 52-week low | $0.1284 |
| Median price | $0.1922 |
| Average price | $0.1908 |
| Largest weekly change | -45.1% (Nov 20, 2024) |
| Weeks tracked | 394 |
| Tracking since | Dec 12, 2018 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 30 MG TABLET, manufactured by Winder Laboratories LLC, is $0.1284 per EA (NDC 75826013810), effective Jun 24, 2026.
How has the price of PHENOBARBITAL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 30 MG TABLET has declined 41.4%. It has been tracked across 394 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 30 MG TABLET?
Since Dec 12, 2018, the NADAC for PHENOBARBITAL 30 MG TABLET has ranged from a low of $0.0913 (Nov 20, 2024) to a high of $0.2865 (Jun 10, 2020), with a median of $0.1922 per EA.
Are there cheaper alternatives to PHENOBARBITAL 30 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as PHENOBARBITAL 30 MG TABLET, but none are currently priced below it.
Who manufactures PHENOBARBITAL 30 MG TABLET?
PHENOBARBITAL 30 MG TABLET (NDC 75826013810) is labeled by Winder Laboratories LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification